Latest Articles about BIIB

Biogen Submits Plegridy BLA - Analyst Blog

Zacks Equity Research — Fri, 24 May 2013 01:28:10 Z

Biogen Idec ( BIIB ) recently submitted a Biologics License Application (BLA) in the US for its multiple sclerosis candidate, Plegridy (peginterferon beta-1a). The company is looking to

Additional Patent for Acorda's Ampyra - Analyst Blog

Zacks Equity Research — Wed, 22 May 2013 23:25:51 Z

Acorda Therapeutics, Inc. ( ACOR ) recently announced that an additional method of use patent (US patent application no. 8,440,703) related to Ampyra twice-daily dosing of less than 15 mg

Positive Data on Novo Nordisk's N9-GP - Analyst Blog

Zacks Equity Research — Wed, 22 May 2013 01:27:42 Z

Novo Nordisk ( NVO ) recently announced positive phase III data on its hemophilia B candidate, N9-GP, from the paradigm 2 study. Paradigm 2 evaluated N9-GP, a long-acting FIX derivative,

Biogen's Hemophilia BLA Accepted - Analyst Blog

Zacks Equity Research — Mon, 20 May 2013 18:25:38 Z

The US Food and Drug Administration (FDA) recently accepted Biogen Idec's ( BIIB ) Biologics License Application (BLA) for its hemophilia A candidate, Eloctate (recombinant factor VIII Fc

Buzz on the Street: This Bull Is Half Honey Badger, Half Terminator

Minyanville Staff — Fri, 17 May 2013 23:00:00 Z

All day and every day, some of the stock market's best and brightest traders and money managers share their ideas, insights, and analysis in real-time on Minyanville's Buzz & Banter.

Isis Gets $3.5M Milestone Payment - Analyst Blog

Zacks Equity Research — Wed, 15 May 2013 00:05:59 Z

Isis Pharmaceuticals Inc. ( ISIS ) recently announced that it has received a milestone payment of $3.5 million from its partner, Biogen Idec Inc. ( BIIB ). The milestone payment was

Market Close Report: NASDAQ Composite index closes at 3,438.79 up 2.21 points

NASDAQ.com News — Tue, 14 May 2013 00:45:16 Z

Monday's session closes with the NASDAQ Composite Index at 3,438.79. The total shares traded for the NASDAQ was over 1.59 billion. Declining stocks led advancers by 1.2 to 1 ratio. There were

Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2013

NASDAQ.com News — Mon, 13 May 2013 15:39:06 Z

Amgen Inc. ( AMGN ) will begin trading ex-dividend on May 14, 2013. A cash dividend payment of $0.47 per share is scheduled to be paid on June 07, 2013. Shareholders who purchased AMGN stock

S&P Highlights Biotech ETFs

ETF Professor — Fri, 10 May 2013 15:39:21 Z

Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis,

Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog

Zacks Equity Research — Wed, 08 May 2013 18:25:10 Z

Seattle Genetics, Inc. ( SGEN ) reported first quarter 2013 net loss per share of 14 cents, narrower than the Zacks Consensus Estimate of a loss of 19 cents, but wider than the year-ago

Bayer Discontinues Hemophilia Study - Analyst Blog

Zacks Equity Research — Tue, 07 May 2013 01:23:16 Z

Bayer 's ( BAYRY ) HealthCare segment recently decided to discontinue the phase II/III TRUST (TReatment with Unique recombinant rFVIIa STudy) study on BAY 86-6150. The study was evaluating

Acorda Incurs Loss, Maintains Guidance - Analyst Blog

Zacks Equity Research — Mon, 06 May 2013 23:25:55 Z

Acorda Therapeutics Inc. 's ( ACOR ) first quarter 2013 loss (including share-based compensation charges but excluding other special items) of 3 cents per share compared unfavorably with

Top Fund Buys Focus On Defensive Stocks, Housing

Investor's Business Daily — Fri, 03 May 2013 01:45:00 Z

April notched another month of gains for the stock market. That's four straight months so far this year. But this market rally is getting long in the tooth and top fund managers have been

Equal-Weight ETF Trounces Traditional S&P 500 Peers

ETF Professor — Tue, 30 Apr 2013 19:15:38 Z

Just over two decades ago, the SPDR S&P 500 (NYSE: SPY ) was born, forever altering the U.S. investment landscape in the process. Today, SPY is the world's largest ETF with nearly

Market Close Report: NASDAQ Composite index closes at 3,307.02 up 27.76 points

NASDAQ.com News — Tue, 30 Apr 2013 00:45:11 Z

Monday's session closes with the NASDAQ Composite Index at 3,307.02. The total shares traded for the NASDAQ was over 1.54 billion. Advancers stocks led declining by 2.12 to 1 ratio. There were